Eventide Asset Management - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 190 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$14,662,352
+4.3%
459,2030.0%0.25%
-3.9%
Q1 2023$14,060,796
+34.6%
459,203
+72.0%
0.26%
+25.2%
Q4 2022$10,443,348
-17.9%
267,0250.0%0.21%
-17.6%
Q3 2022$12,721,000267,0250.25%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
SC CHINA HOLDING Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.61%
Alphabet Inc. 321,604$10,268,8150.55%
View complete list of BEAM THERAPEUTICS INC shareholders